omniture
logo
Search
GUARDANT HEALTH PTE LTD
Media Room

Latest News

rss

Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations

* Guardant360® CDx is the first blood-based companion diagnostic to be approved inJapan for the d...

2024-08-30 11:01 4400

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

PALO ALTO, Calif., Jan. 8, 2024 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading preci...

2024-01-08 15:30 2138

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision on...

2023-11-13 08:00 3607

Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers

* Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical informa...

2023-05-30 09:00 3578

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio ...

2022-07-06 18:17 4511

Guardant Health Receives Regulatory Approval for Guardant360 CDx in Japan

TOKYO, March 14, 2022 /PRNewswire/ -- The Ministry of Health, Labour and Welfare (MHLW) has granted...

2022-03-14 16:22 2900

Guardant360 CDx submitted for regulatory approval in Japan

TOKYO, Feb. 3, 2021 /PRNewswire/ -- Guardant Health Japan, an affiliate of Guardant Health Asia,Mid...

2021-02-03 18:41 3502